Sugar Editorial Picks
Jul 16, 2007 -
The folks at Fitness, the magazine that is, are savvy to our changing nutritional needs. As we age our bodies and our lifestyles change. Curious if you are meeting the nutritional challenges of your generation?
- 11 Comments
Other Search Results
Sep 04, 2008 -
Overview
- Definition
- Alternative Names
- Considerations
- Common Causes
- Home Care
- Call your health care provider if
- What to expect at your health care provider's office
- References
Illustrations
Female reproductive anatomy
Painful periods (dysmenorrhea)
Relieving PMS
Uterus
HEALTH GUIDE REFERENCE FROM A.D.A.M
Definition
Painful menstrual periods are periods in which a woman experiences crampy lower abdominal pain, sharp pain that comes and goes, aching pain, or possibly back pain.
Alternative Names
Menstruation - painful; Dysmenorrhea; Periods - painful; Cramps - menstrual; Menstrual cramps
Considerations
Painful menstruation affects many women. For a small number of women, the discomfort makes it difficult to perform normal household, job, or school-related activities for a few days during each menstrual cycle.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- What Causes It?
- Who's Most At Risk?
- What to Expect at Your Provider's Office
- Treatment Options
- Prognosis/Possible Complications
- Following Up
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Muscular dystrophy (MD) is a group of genetic diseases involving progressive weakness and degeneration of the muscles that control movement. In some forms of MD, the heart muscles and other involuntary muscles, as well as other organs, are also affected. There are nine distinct types of MD.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Dietary Factors
- Prevention
- Diagnosis
- Staging
- Prognosis
- Surgery
- Medications
- Radiation Treatment
- Follow-up Testing
- Treatment for Metastasized ...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In September 2006, the Food and Drug Administration approved panitumumab (Vectibix) for the treatment of patients with colorectal cancer that has spread to other parts of the body following chemotherapy. Like cetuximab (Ertibux), panitumumab targets the epidermal growth factor receptor (EGFR) on cancer cells. Panitumumab is the first new colorectal cancer drug approved since 2004.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Symptoms
- Diagnosis
- Outlook
- Staging and Treatment Guide...
- Treatment Options by Stage...
- Radiation Treatments
- Chemotherapy
- Transplantation
- Immunotherapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
Chemotherapy can cause anemia, a drop in red blood cell (hemoglobin) levels. Erythropoiesis-stimulating drugs, which boost the production of red blood cells, are administered to counteract this complication. However, these drugs, including epoietin alfa (Epogen, Procrit) and darbepoietin alfa (Aranesp), can also cause serious side effects and adversely affect survival when hemoglobin levels are raised too high.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Lifestyle or Psychological ...
- Physical Causes
- Prognosis
- Diagnosis
- Treatment
- Lifestyle Changes
- Medications
- Injections or Topical Treat...
- Other Treatments
- Natural Remedies
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
FDA Warns about Dietary Supplements
In 2006 and 2007, the FDA issued numerous warnings about “natural” dietary supplements promoted for erectile dysfunction and sexual enhancement. These products -- marketed under names such as “True Man,” “Energy Max,” “Rhino Max”-- contain illegal substances that can interact with prescription drugs and dangerously lower blood pressure. The interaction risks are greatest for men with diabetes, high blood pressure, high cholesterol, or heart disease who take prescription drugs that contain nitrates.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Prognosis
- Risk Factors
- Symptoms
- Conditions with Similar Sym...
- Screening and Diagnosis
- Tests to Determine Severity...
- Treatment
- Treatment Options by Stagin...
- Treatment for Localized Pro...
- Surgery
- Radiation Treatments
- Options if Treatments Fail...
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
New Guidelines for Localized Prostate Cancer
In 2007, the American Urological Association (AUA) released updated guidelines for treatment of localized prostate cancer. The guidelines recommend that:
- Patients should be classified as low, intermediate, or high risk, depending on their PSA levels, cancer stage, and tumor aggressiveness.
- Doctors need to consider patients’ personal preferences and quality of life concerns as well as their clinical status.
- Standard treatment options include active surveillance (watchful waiting), surgery, or radiation therapy. Initial androgen deprivation therapy (hormone therapy) is seldom recommended for localized prostate cancer.
New Guidelines for Androgen Deprivation Therapy
- The American Society of Clinical Oncology (ASCO) 2007 guidelines recommend that doctors delay androgen deprivation therapy for advanced prostate cancer until patients develop symptoms.
- 0 Comments